SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-186702
Filing Date
2021-06-09
Accepted
2021-06-09 16:03:36
Documents
12
Period of Report
2021-04-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d119699d8ka.htm   iXBRL 8-K/A 23425
  Complete submission text file 0001193125-21-186702.txt   146068

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aveo-20210415.xsd EX-101.SCH 2736
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20210415_lab.xml EX-101.LAB 18060
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20210415_pre.xml EX-101.PRE 11373
5 EXTRACTED XBRL INSTANCE DOCUMENT d119699d8ka_htm.xml XML 4039
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-34655 | Film No.: 211005163
SIC: 2834 Pharmaceutical Preparations